Segment and Geographic Information (Tables)

6 Months Ended

Oct. 25, 2019

The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:

Net Sales


	Three months ended⁽¹⁾						Six months ended⁽¹⁾
(in millions)	October 25, 2019		October 26, 2018		October 25, 2019		October 26, 2018
Cardiac and Vascular Group	$	2,855	$	2,858	$	5,645	$	5,669
Minimally Invasive Therapies Group	2,142		2,047		4,242		4,099
Restorative Therapies Group	2,112		1,993		4,124		3,942
Diabetes Group	596		583		1,188		1,155
Total	$	7,706	$	7,481	$	15,199	$	14,865

(1) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum.

Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated

Segment Operating Profit


	Three months ended						Six months ended
(in millions)	October 25, 2019		October 26, 2018		October 25, 2019		October 26, 2018
Cardiac and Vascular Group	$	1,128	$	1,137	$	2,183	$	2,186
Minimally Invasive Therapies Group	823		792		1,593		1,568
Restorative Therapies Group	840		804		1,633		1,570
Diabetes Group	148		176		297		348
Segment operating profit	2,939		2,909		5,706		5,672
Interest expense	(165)		(241)		(774)		(483)
Other non-operating income, net	108		52		209		238
Amortization of intangible assets	(441)		(445)		(881)		(891)
Corporate	(350)		(342)		(657)		(645)
Centralized distribution costs	(424)		(482)		(768)		(928)
Restructuring and associated costs	(94)		(77)		(218)		(190)
Acquisition-related items	(27)		(4)		(46)		(40)
Certain litigation charges	(121)		—		(168)		(103)
IPR&D charges	—		(15)		—		(15)
Exit of businesses	(41)		—		(41)		(80)
Debt tender premium and other charges	—		—		7		—
Medical device regulations	(10)		—		(18)		—
Contribution to Medtronic Foundation	(80)		—		(80)		—

Income before income taxes	$	1,294	$	1,355	$	2,271	$	2,535

Net Sales to External Customers by Geography

The following table presents net sales for the three and six months ended October 25, 2019 and October 26, 2018 for the Company's country of domicile, countries with significant concentrations, and all other countries:


	Three months ended						Six months ended
(in millions)	October 25, 2019		October 26, 2018		October 25, 2019		October 26, 2018
Ireland	$	23	$	22	$	43	$	44

United States	4,129		4,045		8,046		7,909
Rest of world	3,554		3,414		7,110		6,912
Total other countries, excluding Ireland	7,683		7,459		15,156		14,821
Total	$	7,706	$	7,481	$	15,199	$	14,865